Free Trial

Vitalhub Corp. (TSE:VHI) Given Consensus Rating of "Buy" by Brokerages

Vitalhub logo with Medical background

Shares of Vitalhub Corp. (TSE:VHI - Get Free Report) have been given a consensus rating of "Buy" by the five analysts that are presently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is C$10.05.

Several equities research analysts have recently weighed in on the company. TD Securities raised Vitalhub to a "strong-buy" rating in a research report on Monday, November 25th. Scotiabank set a C$14.00 target price on shares of Vitalhub and gave the company an "outperform" rating in a research note on Thursday. Cormark lifted their price objective on shares of Vitalhub from C$9.50 to C$10.50 and gave the stock a "buy" rating in a report on Wednesday, October 2nd. Finally, Canaccord Genuity Group increased their price target on Vitalhub from C$12.00 to C$12.50 and gave the stock a "buy" rating in a research report on Thursday, January 16th.

Get Our Latest Report on VHI

Vitalhub Stock Performance

Shares of TSE:VHI traded up C$0.25 during trading on Thursday, reaching C$11.73. 68,152 shares of the stock were exchanged, compared to its average volume of 126,380. The firm's 50-day moving average price is C$11.26 and its 200 day moving average price is C$9.63. Vitalhub has a 12-month low of C$4.36 and a 12-month high of C$12.09. The firm has a market cap of C$596.47 million, a price-to-earnings ratio of 106.64, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26.

Vitalhub Company Profile

(Get Free Report

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Read More

Analyst Recommendations for Vitalhub (TSE:VHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines